This, the company says, makes Simparica Trio the only oral moxidectin that is licensed to treat A.vasorum in dogs in the UK.
Louise Longstaff, National Veterinary Manager at Zoetis UK said: “The last time a product was licensed for the treatment of lungworm in the UK was some time ago, so this is an especially important development.
"Simparica Trio offers a new licensed route of administration for lungworm treatment in dogs, giving vets another option to that which is currently available.
"It enables them to tailor treatment based on their patient’s needs while still prescribing within the cascade.”
Simparica Trio is a chewable monthly tablet for dogs containing sarolaner, moxidectin and pyrantel.
It kills fleas and ticks, treats mites, roundworm and hookworm, prevents and treats lungworm and prevents heartworm disease.
https://www.noahcompendium.co.uk/?id=-485011
Giles is the professor of molecular neuroendocrinology at the Medical Research Council Metabolic Diseases Unit and scientific director of the Genomics/Transcriptomics Core at the University of Cambridge.
He is a well-known broadcaster thanks to his appearances on programmes such as BBC’s ‘Horizon’ and ‘Trust me, I’m a Doctor’ and author of two books: Gene Eating: The Story Of Human Appetite and Why Calories Don't Count.
He also hosts the podcast Dr Giles Yeo Chews The Fat.
Giles and his colleagues at the University of Cambridge recently identified a genetic mutation in Labrador retrievers that significantly increases their propensity for obesity and food motivation.
This mutation, a 14-base pair deletion in the POMC gene, disrupts the production of beta-MSH and beta-endorphin, hormones involved in regulating appetite and energy balance.
The study found this mutation is present in about 25% of Labradors and 66% of flat-coated retrievers, and is also more common in assistance dogs than pet Labradors.
Giles' lecture: "The genetics of obesity: Can an old dog teach us new tricks?" will lay out the evidence for a genetic basis to body weight and explore the role of the leptin-melanocortin pathway in both human and dog obesity, and its conservation through evolution.
Giles said: “It is clear that the cause of obesity is a result of eating more than you burn.
"It is physics.
"What is more complex to answer is why some people eat more than others?
"Differences in our genetic make-up mean some of us are slightly more hungry all the time and so eat more than others.
"I will highlight the fat-sensing 'leptin-melanocortin' pathway, as a key appetite control circuit.
"Not only is the pathway conserved in all mammals and many higher vertebrates, but genetic disruption of the pathway as an evolutionary strategy to influence feeding behaviour has also been conserved. In contrast to the prevailing view, obesity is not a choice.
"People who are obese are not bad or lazy; rather, they are fighting their biology.”
British Veterinary Association President Elizabeth Mullineaux said: “I’m sure our BVA Congress delegates will appreciate both Dr Yeo’s scientific knowledge and his dynamic delivery style and I’m personally looking forward to learning more about this exciting topic.”
https://london.vetshow.com
The model was trialled at the group's Rotherham practice where it has introduced advanced soft tissue surgery, 128-slice CT scanning, orthopaedics and spinal surgery, cardiac scanning and ophthalmology.
To offer the service, the group has invested £280K in post-graduate qualifications for its vets and £130k in equipment over the past 18 months.
The Pet Vet Says that not only does the ‘First Opinion Plus’ model expand the group’s ability to serve more pets in their communities, it has also boosted recruitment and retention of clinical colleagues by offering rewarding technical career pathways in addition to traditional leadership routes.
Emily Chapman, Area Manager at The Pet Vet, said: “The implementation of the ‘first opinion plus’ model at The Pet Vet Rotherham has transformed our offering to customers and referring surgeries.
We’ve taken that success and tailored it for each of our 12 surgeries, so every local community we serve benefits from the best of both worlds: trusted first opinion care and advanced services under one roof, as well as a stable and motivated team of colleagues that are supported in pursuing their clinical passions.”
www.thepetvet.co.uk/careers.
The working group, which is led by Gudrun Ravetz, IVC's Group Chief Medical Officer, has been tasked with developing evidence-based, sustainable prescribing practices that protect animal health while safeguarding the planet.
The group comprises experts from within IVC Evidensia’s network who will collaborate with industry and academic partners including Vetoquinol, IDEXX, ESCCAP, and MSD Animal Health to deliver research, education, and practical tools for veterinary teams both inside and outside of IVC Evidensia practices.
Gudrun said: “We’re proud to be investing in this work and setting an example for the profession.
"Responsible parasiticide use is not just a clinical issue, it’s a sustainability imperative.”
Photo: www.depositphotos.com
Faecal calprotectin is a calcium-binding protein released into the gut lumen predominantly by neutrophils, and to a lesser extent by monocytes and macrophages, during intestinal inflammation.
Its presence in faeces reflects the degree of neutrophilic infiltration in the gut mucosa, making it a useful biomarker for identifying intestinal inflammation.
Faecal calprotectin lateral flow testing is already used in human health and included in the NICE guidelines for the management of inflammatory bowel disease (IBD)1.
Determining the underlying cause of chronic diarrhoea, vomiting and weight loss in cats and dogs can be complex, often requiring invasive procedures such as endoscopy or biopsy - both of which carry cost, risk, and sometimes practical limitations in general practice.
GIQuest is designed to offer a non-invasive, rapid alternative to support clinical decision-making.
Carus says that whilst not a replacement for histopathology, faecal calprotectin concentrations have been shown to correlate with disease severity in dogs and cats, as measured by tools such as the Canine Chronic Enteropathy Clinical Activity Index (CCECAI).2
New data from the University of Bristol Vet School appears to confirm the test’s ability to differentiate dogs with histologically-confirmed inflammatory enteropathy from healthy controls with high sensitivity (94%) and specificity (96%) using a score threshold of 3mg/kg.2
Carus says the test also performed well in cats, distinguishing those with inflammatory enteropathy from healthy controls with a specificity of 100% and sensitivity of 92%.
In addition, the test detected elevated calprotectin levels consistent with inflammatory gastroenteropathy in 25% of dogs receiving oral NSAIDs, which highlights its potential not only in long-term monitoring but also early in treatment when GI side effects may first emerge.
Jolian Howell of Carus Animal Health said: “Faecal calprotectin testing can provide additional clarity in a range of clinical scenarios.
"It is particularly useful when diagnosing and managing suspected inflammatory enteropathy or food related reactions and for monitoring or screening for GI side effects of oral non-steroidal anti-inflammatories in long term OA therapy regimes.”
The Bristol study also showed that dogs with food-responsive enteropathy had a significant drop in calprotectin concentrations following dietary change, reinforcing the test’s role in tracking treatment response.
Georgie Louca, Veterinary Business Manager for Carus Animal Health, added: ”By providing a measurable, visual indicator of intestinal inflammation, GIQuest also helps support client communication and can improve compliance during treatment or dietary trials.”
GIQuest is designed for use in practice, including during consultations, delivering colour-coded results in 15 minutes.
GIQuest is now available to veterinary practices across the UK and can be ordered through veterinary wholesalers NVS, Covetrus and MWI.
https://carusanimalhealth.com/giquest
References
They say that the free system offers an easy way for veterinary practices to improve client service, streamline workflows, and enhance animal welfare.
Boop uses AI and computer vision to auto-populate vaccination details and capture things like microchip numbers, to ensure certificates are positively identifiable and compliant with the RCVS 10 principles of certification and electronic signing guidance.
Pet owners can then store and access digital vaccination certificates on their mobile phone through the Boop app, where they can also look-up chip details, up to 30% of which are not properly registered.
The app also lets owners share vaccination certificates easily with boarding and day care establishments via email or whatsapp.
Charlie said: “Boop brings a vaccination record service fit for 2025, enabling vets to add more value to their vaccination service and owners to care better for their pet.
"By linking to the microchip, vets can be confident that every record belongs to the right pet—making care safer, more accurate, and more convenient.”
Once signed up, practices can start issuing digital vaccination certificates immediately, without changing their existing PMS or workflows.
www.booppet.app/vets
For the study, researchers from the RVC, University of Edinburgh and Scotland’s Rural College analysed data from the RVC’s VetCompass Programme on a random sample of 2,440 nail clipping cases taken from over 2 million dogs under UK primary veterinary practice care during 2019, 5.64% of UK dogs (over one in twenty dogs) were found to have had their nails clipped at least once as part of their primary veterinary care each year.
The nail clipping was the primary reason for attending the veterinary visit for more than half (59.40%) of those dogs.
The most cited clinical reasons for nail clipping veterinary visits were overgrown and/or ingrown nails (12.66%) and broken claws or dewclaws (8.84%).
Of the breeds that were most likely to present for nail-clipping, 13.29% of chihuahuas were clipped each year, 12.58% of beagles, 11.98% of greyhounds and 9.36% of pugs.
Dog breeds with a skull shape that deviated from a typical medium-length skull in either direction also had a higher risk of needing nail clipping.
Flat-faced dogs breeds (e.g. pugs, French bulldogs, shih tzus) were 1.67 times more likely to have their nails clipped, while breeds with long faces (e.g. greyhound, whippet) were 1.32 times more likely to have their nails clipped, compared to breeds with a medium length skull (e.g. Labrador retriever, English springer spaniel).
Dog breeds with shortened and often twisted legs (chondrodystrophic breeds) were also 1.44 times more likely to have their nails clipped compared to dog breeds with straight legs.
Age and body weight also affected a dog’s chances of undergoing nail clipping.
Young dogs aged between 1 to 2 years were the most likely to have nail clipping procedures.
Smaller dogs weighing less than 10.00 kg had higher odds of overgrown nails compared to larger dogs weighing 40.00 kg or more.
The researchers say that frequency of nail clipping in primary veterinary care indicates the need for comprehensive teaching of canine nail care in veterinary and veterinary nursing education, as well as proactive veterinary monitoring, nail care protocols and owner education.
Dr Dan O’Neill, Associate Professor of Companion Animal Epidemiology at the RVC and co-author of the paper, said: “This new VetCompass study shows that some dog breeds have more than twice the need to have their nails clipped compared to other breeds.
"This highlights just how distinct humanity has made each dog breed and suggests we are getting close to the time when we should no longer consider all dog breeds as even being the same species.”
Dr Lavin Ahmed, Veterinary Surgeon, President of Protecting Animals in Kurdistan Organization (PAKO) and lead author of the study, said: “When I was first offered nail clipping by RVC VetCompass as my MSc research topic, I honestly underestimated its significance.
"It seemed like just another routine procedure that we all do every day in veterinary practice.
"However, reading the clinical records made it clear that nail care is more than just a trivial grooming procedure but is a genuine welfare issue that deserves much more attention in both veterinary training and owner education.”
Reference
Zenrelia is a new JAK inhibitor which Elanco says provides visible itch relief which lasts 24 hours, from the first dose.1
The company points to a head-to-head study with over 330 dogs across 25 vet clinics, in which Zenrelia was shown to get nearly 50% more itchy dogs back to normal than Apoquel (oclacitinib).1
Elanco says its once-daily dosing may also improve treatment compliance over twice-daily alternatives.
The company also says that Zenrelia has a cost benefit too, presumably meaning it's cheaper than alternatives.
Zenrelia can be given long term with commonly used medications, including vaccines, antibiotics, parasiticides and NSAIDs.
Elanco UK & Ireland General Manager Matthew Frost said: “With this treatment, we’re looking at happier dogs and their owners, and a more rewarding experience for vets.”
www.zenrelia.co.uk
There are four events: two webinars, a face-to-face event with a workshop and a presentation at this year’s BVNA Congress.
The first webinar: ‘OA pain, awareness and management: how veterinary teams can collaborate to effectively manage OA’, takes place on Thursday 7th August (7-8pm).
The second webinar: ‘Librela clinical update; 4 years of clinical experience’ is on Tuesday 19th August (7-8pm).
The face-to-face event: ‘OA pain, awareness and management: how veterinary teams can collaborate to effectively manage OA’ and ‘Librela clinical update; 4 years of clinical experience’ plus practical application workshops, is on Saturday 6th September (10am-1pm) at BVNA HQ Harlow, Essex.
Finally, the BVNA Congress presentation: ‘The Joint Approach; the importance of the nursing team in OA diagnosis and management is on Sunday 12th October (9-10am) and it is free for everyone.
Jayne Clark, Zoetis National Veterinary Manager, Pain. “We are aiming for the talks to enhance delegates’ confidence in navigating aspects of pain management in dogs and cats so that they can support pet and owners with the latest knowledge, in a highly informed, confident and objective way.”
https://bvna.org.uk/events
David, Appleton Professor in Equine Surgery, University of Florida (pictured, left), says that despite considerable progress since the 1970's, largely through improved understanding of the diseases involved, diagnostic methods, surgical equipment and materials, and specialised training of surgeons, lingering problems remain and need to be addressed at all levels, not just by surgeons.
He said: “The current high cost of colic surgery can deny many horses a life-saving procedure.
"Pessimism is likely the product of past failures and overemphasis of treatments that are inappropriate or misdirected.
"Delays in referral might seem minor but have devastatingly harmful effects on outcome.
"Owners, primary care veterinarians, and surgeons need to establish an approach to colic based on teamwork, education, and rejection of myths that are widely promulgated.
"I will be looking at the key elements of progress and how they can be applied for future success.”
Professor Scott Weese (pictured right) is Director of the Centre for Public Health and Zoonoses at the University of Guelph.
He will present: "Misconceptions, Myths and Dogmas: moving past old barriers to optimise antimicrobial use in horses", which will challenge the audience to think about what they do with antibiotics and why, with the aim of introducing practical steps to optimise antimicrobial use, leading to improved patient outcomes, easier treatment and minimisation of negative consequences.
Scott said: “We do a lot of things simply because we’ve done them, not because they work or make sense, and we need to look at what we’re doing and the available evidence.
"I will discuss some well-established dogmas that don’t actually make sense, cover some common questions and misconceptions about antibiotic use, and try to help us advance how we use these life-saving drugs that, to some degree, are a non-renewable resource.”
Scott will also be presenting a talk about sampling on the Friday in the antimicrobial stewardship session, with the aim of getting everyone thinking about how we make antibiotic decisions: “There’s a lot of emphasis on submitting cultures, but if we submit bad samples or can’t interpret them, it’s at best a waste of money and at worst can harm patients.”
Book before 6th August to take advantage of early bird prices for BEVA members of £599 for a three-day pass for vets (normal price £699) and £225 for vet nurses (normal price £273) (with concessionary rates available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Early bird rates and practice passes are available until 6 August 2025.
http://www.bevacongress.org
The project was launched in 2016 to identify and find solutions to some of the specific issues facing the veterinary nursing profession.
However, the organisations say that whilst they both want to make sure veterinary nursing remains a vibrant, rewarding and sustainable profession, they now recognise the benefits of the regulator and the representative body working more independently.
Lyndsay Hughes, BVNA President, said: “The joint decision to end the project marks an end of an era, but also the beginning of an exciting new chapter.
"We will continue to work with each other on activities and projects that support the veterinary nursing profession on an ongoing basis.”
To that end, the RCVS and BVNA have identified the need to continue to drive the effective use of veterinary nurses within the wider veterinary team, in order to promote job satisfaction, progression opportunities and excellent standards of patient care.
The BVNA published resources earlier this year designed to help maximise the RVN role within the current legislation, and there's a ‘RVN utilisation champions’ campaign launching later this year, and streams on the subject at BVNA Congress in October.
The association is also preparing a ‘Nurse Utilisation Toolkit’ which is due to launch in late 2025/early 2026 - to provide members with access to resources on how to implement and support effective use of nurses in the workplace.
The RCVS has recently launched the second phase of the VN Vision initiative which aims to inspire a cultural shift in how veterinary nurses can be more effectively integrated within multidisciplinary veterinary teams, and explore why doing so is essential for the future of veterinary healthcare.
A series of workshops ‘A vision or a necessity: strengthening the role of veterinary nurses in team-based veterinary healthcare’ is being held across the UK for all members of the veterinary team this year, with an additional session being held at BVNA Congress.
https://vnfutures.org.uk
This allows patients to try the drug at lower cost, before progressing to the 30ml bottle for ongoing treatment.
Samantha Taylor, RCVS Recognised Specialist in Feline Medicine said: “It’s great we now have the option to prescribe the smaller 12ML bottle for starting cats on Senvelgo, as it means we don’t have to worry about wasting a 30ml bottle if it becomes evident that the cat requires insulin in the first couple of weeks.”
https://senvelgo.co.uk
The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
https://chestergates.org.uk/referral-services.
The authors say the research marks a significant step forward in understanding how veterinary surgeons and owners can more effectively manage and prevent outbreaks of the disease.
For the study, researchers from the RVC, the University of Cambridge, the Swedish University of Agricultural Sciences and Redwings Horse Sanctuary, analysed more than 500 S. equi samples from across the UK between 2016 and 2022.
In particular, they wanted to better understand the relative contribution of short-term (immediately post infection) versus long-term carriers (carriers that were infected months or years prior).
The samples were collected from clinical cases sent to diagnostic laboratories by veterinary surgeons seeking confirmation of infection.
Surplus samples were submitted to the Surveillance of Equine Strangles network and then cultured in the RVC’s research laboratory and their DNA extracted and sequenced to reveal each bacterium’s complete genetic code.
Adopting an approach that combined whole genome sequencing and epidemiological data, the researchers were able to trace how strains are related and have evolved.
With the use of computer programmes, they also tracked how genetically related strains spread between horses and across regions, over time.
By adopting this approach, the team was also able to pinpoint likely transmission events and chains of infection.
The main findings were:
The research highlights the need for early diagnosis, isolation and laboratory-confirmed clearance, particularly through guttural pouch testing, before assuming a horse is infection-free.
It also advocates for tighter biosecurity and movement protocols, especially when transporting horses across regions.
Dr Abigail McGlennon, former PhD student in the Department of Pathobiology and Population Sciences at the RVC, and lead author of the paper, said: “Strangles is a challenging and distressing disease for horses, owners, yards and vets, and this work has highlighted just how easily it can be spread across the UK in a short period of time.
“This study shows how important enhanced surveillance utilising epidemiological and genomic data is to investigate and understand strangles transmission across the UK.
"Our data highlights the importance of greater awareness and adoption of post-outbreak screening protocols to confirm freedom from infection, rather than owners assuming recovery based on the resolution of clinical signs.”
The new Tosoh AIA 900 analysers have been trialled for the last 18 months at Liphook Equine Hospital, which was the first practice to introduce ACTH testing for horses 25 years ago and gets hundreds of blood samples every week from veterinary practices all over the UK and Europe.
Professor Andy Durham, who heads up the laboratory at Liphook, said the test period has shown that the new machine produces more accurate results primarily because it’s less sensitive to ACTH degrading in blood samples between collection and receipt by the laboratory.
Andy said: “There are several analytic methods available for use in horses, and we wanted to see if this alternative machine had diagnostic benefits over the ones we’d used previously.
"The ACTH molecule we test for immediately begins to break down after a blood sample is taken, even if you handle it carefully and place it in chilled packaging, but this new analyser is able to detect much more of the degraded ACTH molecule, and therefore it gives a more accurate result.
“As a comparison, ACTH values measured using the previous method suffered about three to four times more degradation over 24 hours.
"What this means for horse owners is that it will reduce the risk of false negative results in ACTH tests, so more horses suffering from Cushing’s disease will receive the treatment they need.”
In testing, the new analysers also demonstrated greater accuracy when measuring insulin levels in blood samples.
https://liphookequinehospital.co.ukhttps://www.rainbowequinehospital.co.uk https://www.rossdales.com
'Evidence-based veterinary medicine at 20 – a commentary on historical, philosophical, practical, and ethical aspects' by David Mills MRCVS, Michael J. Reiss and Madeleine Campbell FRCVS, looks at the history of both evidence-based medicine and EBVM, the moral and ethical arguments for EBVM and the practical barriers.
It concludes that EBVM would be improved by:
Author David Mills MRCVS said: “EBVM has extensively infiltrated the veterinary discourse in the last 20 years and whilst it seems a sensible way of doing medicine, this doesn't always translate into practical improvements.
"Of course we need to base decisions on evidence, and the more reliable that evidence the better the decisions are likely to be.
"But is EBVM the best way?
"Does it serve the individual when the evidence doesn't relate to them or the specifics of their disease?
"Does EBVM help or hinder us in realising welfare improvements for the individual animal?
"In this review of the EBVM movement we examine aspects of the methodology and its practical application and in several areas find it wanting.
"Some of these are practical issues - for example underpowered studies, poor evidence - whilst others are fundamental to the philosophy and practice of EBVM itself such as what is evidence, how it translates to individuals and how we cannot predict the future.
"Evidence-based medicine was forged in the fires of not just accepting eminent pronouncements - in this paper we apply this principle to EBVM itself."
https://veterinaryevidence.org/index.php/ve/article/view/710
The RCVS Regional Question Time sessions give members of the profession a chance to learn about College projects and initiatives directly from the RCVS Officer team, Council members, and senior staff.
There is also an opportunity for open dialogue, where any queries can be raised with the RCVS, in a friendly, informal environment.
Both events will begin with supper and drinks at 6.30pm.
The College says discussion topics will be audience-led but are likely to cover current important topics including workforce issues, the benefits of a new Veterinary Surgeons Act, extra-mural studies (EMS), governance reform, the impact of VetGDP, the Practice Standards Scheme (PSS), and the Competition and Markets Authority investigation.
RCVS President, Tim Parkin, said: “It’s an exciting time for me as I embark on my presidential year, and I’m truly looking forward to engaging with members of our wonderful professions about the issues that matter most to them.
“As I mentioned previously at Royal College Day, we’re currently facing some significant and ongoing challenges – from the CMA investigation and workforce issues, to the critical need for a new Veterinary Surgeons Act.
“Now more than ever, it's essential that we recognise the need for change and commit to engaging with one another in a clear, compassionate, and respectful way.
"Please do come and speak with us at either event – meaningful change cannot happen in silos; we must work together to make progress and your input is key.”
https://www.eventbrite.com/cc/rcvs-question-time-4465993
The Ageing Canine Toolkit, which was developed from research carried out by the University of Liverpool, aims to help both vets and owners provide the best care for senior and geriatric dogs.
It includes information about common health problems that affect ageing dogs and a colour-coded checklist to help owners know when to seek advice from a veterinary practice and how to guide discussions during consultations.
As part of the partnership, NationWide Laboratories will be distributing the toolkit to its clients, helping raise awareness and make sure that the owners of older dogs know how to look for signs of disease which could enable treatment to be started earlier.
Alison Selby, Fundraising Manager for BSAVA PetSavers said: “We are thrilled to be embarking on this partnership with NationWide Laboratories.
"By supporting the print and distribution costs of this invaluable resource, they will help us reach more pet owners across the UK.
"Working together in partnership, we hope to equip owners with the knowledge and confidence to support their dogs through the ageing process, ultimately improving their quality of life.”
https://bsava.com/petsavers/our-impact/citizen-science-project
The new RVN Council members are: Emily Bacon RVN, Macauly Gatenby RVN, Dan Lidgbird RVN and Krishna Mistry RVN, with Alice Langstone taking the student seat.
The incoming BVNA officer team for the 2025/6 term is (pictured left to right): Sarah Holliday RVN – President, Lyndsay Hughes RVN – Senior Vice President, Steph Worsley RVN – Junior Vice President, Nikki McLeod RVN – Honorary Secretary, Hamish Morrin RVN – Honorary Treasurer.
The company's teleradiology and education services are not affected, and will continue as normal.
VET.CT's CEO, Victoria Johnson said: “We are deeply sorry to have to close our teleconsulting specialist case advice service.
"Despite many loyal clients loving it and using the service to the full, wider adoption of teleconsulting has been variable globally since its launch in 2018.
"We have continued to consult, invest in, iterate and adapt the service over the past 7 years to unlock the demand.
"However, despite our efforts, we now have to take the painful and difficult decision to close our client-facing service.
"There are a multiplicity of factors that contribute to the issue and sadly, the ongoing economic pressures mean that the teleconsulting service is no longer sustainable.
"We want to reassure our clients that our quality-focused radiology reporting and education services are unaffected by these changes and continue to grow.
https://resources.vet-ct.com/statement-about-teleconsulting-service
The Awards are open to all organisations and practice teams across the UK who are using recognised QI techniques to improve outcomes.
The Award categories are as follows:
Ashley Doorly, Head of Quality Improvement at RCVS Knowledge, said: “Now in its seventh year, the RCVS Knowledge Awards continue to highlight the incredible work being done across the veterinary professions to improve patient safety and outcomes, boost team morale, embed evidence-based veterinary medicine, and support more fulfilling careers.
"Over the years, we’ve seen how strong team culture lays the foundation for successful Quality Improvement projects.
“This year, we’re especially excited to receive applications that explore emerging priorities such as sustainability, One Health, and contextualised care.”
https://knowledge.rcvs.org.uk/awards/rcvs-knowledge-awards
The service is designed to make vital support more accessible to those clients who may face challenges visiting the practice, whether that's down to limited mobility, transport difficulties, or simply a pet’s anxiety with travel.
Led by experienced RVNs, the service includes:
Judith Lee, Small Animal Director at Oakhill Veterinary Centre, said: “Our Community Vet Nurse service is all about making it easier for our clients to access the help they need."
https://www.oakhill-vets.com/pets/community-vet-nurse/
The library currently has 28 on-demand recordings, covering a range of sessions on three main themes: people, planet and animals.
They include: ‘Managing emotions in stressful situation’ and ‘Shaping practice culture as a team’, and BVA Congress recordings, such as "Is neutering dogs doing more harm than good?".
BVA President Elizabeth Mullineaux said: “All veterinary professionals will understand the crucial role that CPD plays in maintaining and enhancing our knowledge and skills.
"Whether you're catching up on missed sessions or looking to revisit key topics, the new BVA CPD library can help members stay up to date throughout your career.”
https://mybva.bva.co.uk/cpd-library.html
This year sees BVNA continue a theme of ‘Progression’, to mirror the association’s 60th anniversary year and recognise the progress made in the VN profession during this time.
There will be no less than twenty lecture streams covering:
There will also be hands-on workshops, small group discussions, and drop-in practical learning events throughout.
https://bvna.org.uk/congress
Mr Seymour-Hamilton was originally struck off in 1994 after his Kent practice was found to be unhygienic and unsterile with poor record keeping.
However, he has always maintained that the reason his premises were unhygienic and unsterile was because they were closed.
As in previous applications, he said his reason for applying for restoration was to help him gain recognition for his alleged herbal and natural remedy discoveries and that he had no intention of going back into general practice.
As with previous applications, the Committee said that Mr Seymour-Hamilton has shown no real insight into the conduct underlying the original findings and nor has he shown insight into matters identified by previous restoration hearings.
The Committee also considered that Mr Seymour-Hamilton has been off the Register for some 31 years and would therefore need prolonged, intensive, formal retraining to ensure that he was now fit to practise, without which he might pose a risk to animal welfare.
Mr Seymour-Hamilton's case was not helped by the fact that he indicated that he had practised veterinary surgery while off the Register – including conducting two spay procedures in Calais, France, and treating two of his own dogs for cancer.
He also referred to having cultured faecal bacteria in a witness’ kitchen.
The Committee felt it was concerning that Mr Seymour-Hamilton thought these things were compatible with being on the Register and upholding the professional standards expected of a veterinary surgeon.
Paul Morris, chairing the Committee and speaking on its behalf, said: “Mr Seymour-Hamilton still lacks an understanding as to why he has not been restored in the past.
"Apart from additional CPD, he has not set about effectively addressing any of his shortcomings.
"He relies passionately on his research, yet he does not support that research with any peer-reviewed publications, indeed all his attempts to gain recognition have been rebuffed.”
He added: “The Committee is firmly of the view that after such a prolonged period of failing to be reinstated as a veterinary surgeon, Mr Seymour-Hamilton has to face the reality that his continued applications, taking up time, resources and expense (which is ultimately borne by all those veterinary surgeons who are on the Register), are vexatious and ultimately unlikely to succeed.
“Whilst the College cannot prevent him from continuing to apply to be restored to the Register, Mr Seymour-Hamilton should by now realise that this is not a good use of the College’s finite resources.
"He is now 86 years old and has not practised for over thirty years and in fact has now been off the Register for longer than he was on it.
"This is now the twelfth time he has been found to be not fit to be restored to the Register.
"The Committee hopes Mr Seymour-Hamilton will now take time seriously to reflect and take into account the impact to all concerned of his continued applications, before deciding to submit any more.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings